26065-16-7
ethyl 5-hydroxy-1-methyl-2-((phenylthio)methyl)-1H-indole-3-carboxylate
CAS: 26065-16-7
Molecular Formula: C19H19NO3S
26065-16-7 - Names and Identifiers
26065-16-7 - Physico-chemical Properties
| Molecular Formula | C19H19NO3S |
| Molar Mass | 341.42 |
| Density | 1.23±0.1 g/cm3(Predicted) |
| Boling Point | 558.8±50.0 °C(Predicted) |
| pKa | 9.14±0.40(Predicted) |
Supplier List
View History
26065-16-7
GSK 3117391
4-Thiazolamine,2,5-dihydro-(9CI)
(R)-6-bromo-4-(2-methoxypropylamino)quinoline-3-carboxylic acid
954217-22-2
N-[[(1,2,3,5,6,7-Hexahydro-s-indacen-4-yl)amino]carbonyl]-4-(1-hydroxy-1-methylethyl)-2-furansulfonamide monosodium salt
80923-99-5
1-(4-bromophenyl)-3-[(3S)-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]urea
1,3,5-Triazine-2,4,6(1H,3H,5H)-trione, 1-cyclohexyl-3-methyl-
AURORA KA-6967
GSK 3117391
4-Thiazolamine,2,5-dihydro-(9CI)
(R)-6-bromo-4-(2-methoxypropylamino)quinoline-3-carboxylic acid
954217-22-2
N-[[(1,2,3,5,6,7-Hexahydro-s-indacen-4-yl)amino]carbonyl]-4-(1-hydroxy-1-methylethyl)-2-furansulfonamide monosodium salt
80923-99-5
1-(4-bromophenyl)-3-[(3S)-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]urea
1,3,5-Triazine-2,4,6(1H,3H,5H)-trione, 1-cyclohexyl-3-methyl-
AURORA KA-6967